iControl Chronic Kidney Disease

Stopped early · Not applicable

Conditions studied: Chronic Kidney Diseases

In brief

The proposed study is responsive to the call for obtaining enhanced preliminary data for an external grant resubmission. The goal is to demonstrate a novel approach using digital health tools to help preserve kidney function. The investigators aim to adapt a previous behavioral intervention and conduct formative testing among patients with CKD. Specifically, the investigators will: Aim 1: Modify an existing technology platform to build the iControl CKD system and adapt intervention content to reflect behavioral guidelines for patients with mild to moderate CKD. Aim 2: Conduct qualitative interviews and user testing among patients with CKD to obtain feedback on the design of the intervention. Aim 3: Conduct a prospective cohort feasibility trial to assess the feasibility and initial acceptability of the iControl CKD intervention.

Key facts

Study ID

NCT03951363

Run by

Duke University

People needed

4

Starts

2019-05-13

Expected to finish

2020-02-20

Last updated by the study team

2021-02-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Qualitative interview:
• Age 18 or older
• Diagnosed with CKD (self-report)
• Proficient in English
• Inclusion criteria:
• Pilot Groups:
• Age 18 or older
• Diagnosed with mild to moderate CKD (documented eGFR ≥60 ml/min/1.73m2 plus albuminuria or eGFR 45-59 ml/min/1.73m2 )
• Diagnosed with diabetes and/or hypertension
• Proficient in English
• Access to a test-enabled mobile phone
• Willing to receive and send multiple text messages in a week

Where it is running

• Duke Global Digital Health Science Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.